Dr. Susan W Walker, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 111 Brewster St, Department Of Anesthesia, Pawtucket, RI 02860 Phone: 401-726-7300 Fax: 401-726-7330 |
Dr. Peter E Baziotis, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 111 Brewster St, Anesthesia Department, Pawtucket, RI 02860 Phone: 401-726-7300 Fax: 401-726-7330 |
Lyudmil Lyudmilov Todorov, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 111 Brewster St, Department Of Anesthesia, Pawtucket, RI 02860 Phone: 401-726-7300 Fax: 401-726-7330 |
Jose Francisco De Leon, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 200 Main St Ste 350, Anesthesia Care Inc, Pawtucket, RI 02860 Phone: 401-726-7300 |
Dr. Edgardo Rodriguez, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 111 Brewster St, Anesthesia Department, Pawtucket, RI 02860 Phone: 401-726-7300 Fax: 401-726-7330 |
Ataollah Hassani Afshar, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 200 Main St, Suite 350, Pawtucket, RI 02860 Phone: 401-726-7300 Fax: 401-726-7330 |
News Archive
Provepharm, a French company specialized in the development of pharmaceutical applications, today announces that Daiichi Sankyo, Co. Ltd., a global pharmaceutical firm, has filed an NDA (New Drug Application) for the development and marketing of the injectable Methylene Blue medicinal product in Japan, made out of Provepharm's Proveblue Methylene Blue active substance.
An intervention that targeted modifiable stressors in the home of patients with dementia resulted in better outcomes for the patients and their caregivers at 4 months, but not at 9 months, although the caregivers perceived greater benefits, according to a study in the September 1 issue of JAMA.
Researchers at The University of Nottingham have shown an association between certain past diagnostic radiation procedures and an increased risk of young-onset prostate cancer - a rare form of prostate cancer which affects about 10 per cent of all men diagnosed with the disease.
Baylor Research Institute (BRI), the research arm of Baylor Health Care System, and bioinformatics pioneer Eureka Genomics (EG) have formed a strategic alliance to achieve a better understanding of the causes of colorectal cancer, potentially leading to advancements in the disease's prevention, management and treatment.
› Verified 4 days ago